S&P 500
(1.02%) 5 099.96 points
Dow Jones
(0.40%) 38 240 points
Nasdaq
(2.03%) 15 928 points
Oil
(0.11%) $83.66
Gas
(-3.32%) $1.920
Gold
(0.30%) $2 349.60
Silver
(-0.43%) $27.52
Platinum
(0.42%) $924.40
USD/EUR
(0.32%) $0.935
USD/NOK
(0.67%) $11.02
USD/GBP
(0.13%) $0.800
USD/RUB
(-0.07%) $92.11

Realaus laiko atnaujinimai OraSure Technologies Inc [OSUR]

Birža: NASDAQ Sektorius: Healthcare Pramonė: Medical Instruments & Supplies
BUY
66.67%
return -1.09%
SELL
16.67%
return 3.85%
Atnaujinta26 bal. 2024 @ 23:00

1.14% $ 5.32

PIRKIMAS 104993 min ago

@ $6.92

Išleistas: 14 vas. 2024 @ 21:05


Grąža: -23.07%


Ankstesnis signalas: vas. 14 - 16:30


Ankstesnis signalas: Pardavimas


Grąža: -1.07 %

Live Chart Being Loaded With Signals

Commentary (26 bal. 2024 @ 23:00):
Profile picture for OraSure Technologies Inc

OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices in the United States, Europe, and internationally...

Stats
Šios dienos apimtis 512 701
Vidutinė apimtis 920 458
Rinkos kapitalizacija 392.60M
EPS $0 ( 2024-02-27 )
Kita pelno data ( $0.0400 ) 2024-05-08
Last Dividend $1.600 ( 1998-01-08 )
Next Dividend $0 ( N/A )
P/E 7.39
ATR14 $0.00300 (0.06%)
Insider Trading
Date Person Action Amount type
2024-03-26 Datin James A Buy 3 217 Common Stock
2024-03-26 Datin James A Sell 871 Common Stock
2024-03-01 Mcgrath Kenneth J Buy 58 759 Common Stock
2024-03-01 Mcgrath Kenneth J Sell 5 616 Common Stock
2024-03-01 Anthony Michele Marie Buy 24 336 Common Stock
INSIDER POWER
67.98
Last 97 transactions
Buy: 2 719 008 | Sell: 297 058

Tūris Koreliacija

Ilgas: -0.13 (neutral)
Trumpas: -0.02 (neutral)
Signal:(36.626) Neutral

OraSure Technologies Inc Koreliacija

10 Labiausiai teigiamai susiję koreliacijos
10 Labiausiai neigiamai susiję koreliacijos

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

OraSure Technologies Inc Koreliacija - Valiuta/Žaliavos

The country flag -0.12
( neutral )
The country flag -0.57
( weak negative )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.56
( weak )

OraSure Technologies Inc Finansinės ataskaitos

Annual 2023
Pajamos: $405.47M
Bruto pelnas: $179.42M (44.25 %)
EPS: $0.730
FY 2023
Pajamos: $405.47M
Bruto pelnas: $179.42M (44.25 %)
EPS: $0.730
FY 2022
Pajamos: $387.48M
Bruto pelnas: $147.64M (38.10 %)
EPS: $-0.250
FY 2021
Pajamos: $233.67M
Bruto pelnas: $117.60M (50.33 %)
EPS: $-0.320

Financial Reports:

No articles found.

OraSure Technologies Inc Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)

OraSure Technologies Inc Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 4.02 - Potential for dividend initiation, but uncertain (19.58%)
Information
First Dividend $1.600 1998-01-08
Last Dividend $1.600 1998-01-08
Next Dividend $0 N/A
Payout Date 0000-00-00
Next Payout Date N/A
# dividends 1 --
Total Paid Out $1.600 --
Avg. Dividend % Per Year 0.00% --
Score 2.32 --
Div. Sustainability Score 10.00
Div.Growth Potential Score 4.02
Div. Directional Score 7.70 --
Next Divdend (Est)
(2024-04-27)
$0 Estimate 0.00 %
Dividend Stability
0.00 Very Bad
Dividend Score
2.32
Pay Frequency
Insufficient data to determine frequency
Yearly Payout
Year Amount Yield
1998 $1.600 29.80%
1999 $0 0.00%
2000 $0 0.00%
2001 $0 0.00%
2002 $0 0.00%
2003 $0 0.00%
2004 $0 0.00%
2005 $0 0.00%
2006 $0 0.00%
2007 $0 0.00%
2008 $0 0.00%
2009 $0 0.00%
2010 $0 0.00%
2011 $0 0.00%
2012 $0 0.00%
2013 $0 0.00%
2014 $0 0.00%
2015 $0 0.00%
2016 $0 0.00%
2017 $0 0.00%
2018 $0 0.00%
2019 $0 0.00%
2020 $0 0.00%
2021 $0 0.00%
2022 $0 0.00%
2023 $0 0.00%
2024 $0 0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for NASDAQ

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
SLVO Dividend Royal 2023-11-20 Monthly 12 10.77% 8.50
QYLD Dividend Royal 2023-11-20 Monthly 11 7.50% 8.50
PSEC Dividend Royal 2023-12-26 Monthly 21 7.04% 8.50
GAIN Dividend Royal 2023-12-04 Monthly 20 8.19% 8.50
GLDI Dividend Royal 2023-11-20 Monthly 12 7.15% 8.50
OXLC Dividend Royal 2023-12-14 Monthly 14 10.00% 8.50
OXSQ Dividend Diamond 2023-12-14 Monthly 21 9.10% 8.50
HRZN Dividend King 2023-12-18 Monthly 15 6.60% 8.45
USOI Dividend Royal 2023-11-20 Monthly 8 16.70% 8.28
PFLT Dividend King 2023-11-15 Monthly 14 6.50% 8.27

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.1321.5007.3510.00[0 - 0.5]
returnOnAssetsTTM0.1111.2006.307.56[0 - 0.3]
returnOnEquityTTM0.1321.5009.6410.00[0.1 - 1]
payoutRatioTTM0-1.00000[0 - 1]
currentRatioTTM9.770.80010.008.00[1 - 3]
quickRatioTTM8.360.80010.008.00[0.8 - 2.5]
cashRatioTTM7.351.50010.0010.00[0.2 - 2]
debtRatioTTM0.0280-1.5009.53-10.00[0 - 0.6]
interestCoverageTTM01.000-1.111-1.111[3 - 30]
operatingCashFlowPerShareTTM1.5752.009.4710.00[0 - 30]
freeCashFlowPerShareTTM1.4352.009.2810.00[0 - 20]
debtEquityRatioTTM0.0314-1.5009.87-10.00[0 - 2.5]
grossProfitMarginTTM0.4251.0006.266.26[0.2 - 0.8]
operatingProfitMarginTTM0.09011.000-0.198-0.198[0.1 - 0.6]
cashFlowToDebtRatioTTM8.571.00010.0010.00[0.2 - 2]
assetTurnoverTTM0.8400.8007.736.19[0.5 - 2]
Total Score11.37

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM7.291.0009.360[1 - 100]
returnOnEquityTTM0.1322.509.7710.00[0.1 - 1.5]
freeCashFlowPerShareTTM1.4352.009.5210.00[0 - 30]
dividendYielPercentageTTM01.50000[0 - 0.4]
operatingCashFlowPerShareTTM1.5752.009.4710.00[0 - 30]
payoutRatioTTM01.50000[0 - 1]
pegRatioTTM0.04861.500-3.010[0.5 - 2]
operatingCashFlowSalesRatioTTM0.2861.0005.360[0.1 - 0.5]
Total Score4.02

OraSure Technologies Inc

OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices in the United States, Europe, and internationally. It operates in two segments, Diagnostics and Molecular Solutions. The company's principal products include InteliSwab COVID-19 rapid test, InteliSwab COVID-19 rapid test pro, InteliSwab COVID-19 rapid test rx, OraQuick Rapid HIV test, OraQuick In-Home HIV test, OraQuick HIV self-test, OraQuick HCV rapid antibody test, OraQuick Ebola rapid antigen test, OraSure oral fluid collection device used in conjunction with screening and confirmatory tests for HIV-1 antibodies; Intercept drug testing systems; immunoassay tests and reagents; and Q.E.D. saliva alcohol test. It also offers genomic products under the Oragene and ORAcollect brands; microbiome collection products; and GenoFIND genomics laboratory services. In addition, the company provides ORAcollect, RNA and OMNIgene, and RAL collection devices for use in connection with COVID-19 molecular testing; offers Colli-Pee collection device for the volumetric collection of first void urine; and manufactures and sells kits that are used to collect, stabilize, transport, and store samples of genetic material for molecular testing in the academic research and commercial applications, including ancestry, disease risk management, lifestyle, and animal testing. Further, it provides other diagnostic products, such as immunoassays and other in vitro diagnostic tests. The company markets its products to clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, and commercial and industrial entities. OraSure Technologies, Inc. was incorporated in 2000 and is headquartered in Bethlehem, Pennsylvania.

Apie Signalai gyvai

Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.

Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.